Valdez H - Search Results

1

Rationale for immune-based therapies for HIV-1 infection.

Valdez H, Al-Harthi L, Landay A, Lederman MM. Valdez H, et al. J Lab Clin Med. 1998 Mar;131(3):197-206. doi: 10.1016/s0022-2143(98)90090-7. J Lab Clin Med. 1998. PMID: 9523842 Review. No abstract available.

2

Cytotoxic T-cell activity and progression of HIV disease: abstract and commentary.

Lederman MM, Valdez H. Lederman MM, et al. Among authors: valdez h. JAMA. 1998 Jan 21;279(3):242. doi: 10.1001/jama.279.3.242. JAMA. 1998. PMID: 9438750 No abstract available.

3

Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients.

Valdez H, Purvis S, Asaad R, Valerio I, Sha BE, Landay AL, Lederman MM. Valdez H, et al. Clin Diagn Lab Immunol. 1999 May;6(3):427-8. doi: 10.1128/CDLI.6.3.427-428.1999. Clin Diagn Lab Immunol. 1999. PMID: 10225849 Free PMC article.

4

Rationale for immune-based therapies for human immunodeficiency virus type 1 infection.

Lederman MM, Valdez H. Lederman MM, et al. Among authors: valdez h. AIDS Clin Rev. 2000-2001:229-61. AIDS Clin Rev. 2000. PMID: 10999222 Review. No abstract available.

5

[Manifestation of hyper-IgE syndrome in advanced HIV-1 infection].

Lange CG, Gripshover BM, Valdez H, Lederman MM. Lange CG, et al. Among authors: valdez h. Med Klin (Munich). 2002 Jan 15;97(1):34-9. doi: 10.1007/s00063-002-1122-3. Med Klin (Munich). 2002. PMID: 11831060 German.

6

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM. Lange CG, et al. Among authors: valdez h. Clin Immunol. 2002 Feb;102(2):154-61. doi: 10.1006/clim.2001.5164. Clin Immunol. 2002. PMID: 11846457

7

HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens.

Valdez H, Carlson NL, Post AB, Asaad R, Heeger PS, Lederman MM, Lehmann PV, Anthony DD. Valdez H, et al. AIDS. 2002 May 24;16(8):1113-8. doi: 10.1097/00002030-200205240-00004. AIDS. 2002. PMID: 12004269

8

Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H. Lange CG, et al. Among authors: valdez h. J Acquir Immune Defic Syndr. 2002 May 1;30(1):33-40. doi: 10.1097/00042560-200205010-00005. J Acquir Immune Defic Syndr. 2002. PMID: 12048361

9

Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2.

Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM. Sha BE, et al. Among authors: valdez h. AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):661-5. doi: 10.1089/088922202760019365. AIDS Res Hum Retroviruses. 2002. PMID: 12079562 Clinical Trial.

10

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, St Clair M, Kuritzkes DR, Kessler H, Fox L, Blanchard-Vargas M, Landay A; AIDS Clinical Trials Group Protocol 375 Team. Valdez H, et al. AIDS. 2002 Sep 27;16(14):1859-66. doi: 10.1097/00002030-200209270-00002. AIDS. 2002. PMID: 12351945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters